Contrast-enhanced breast MRI may help rule out malignancy and avoid surgery in patients with high-risk lesions, a systematic review and meta-analysis reveals.
BERLIN--(BUSINESS WIRE)--Bayer, a global leader in radiology, today announced positive topline results of the pivotal Phase III QUANTI studies evaluating the efficacy and safety of gadoquatrane, an ...
Supplementary contrast imaging detected more breast cancers than automated whole-breast ultrasound in women with dense breasts. The invasive tumor size found by abbreviated MRI and contrast-enhanced ...
MENLO PARK, Calif.--(BUSINESS WIRE)--HALO Precision Diagnostics (“HALO”), a leader in early disease detection using precision diagnostics, today announced a collaboration with Bayer, a global leader ...
(Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain--the Swoop (R) system--today ...
Despite such guidelines, though, the investigators said there is a lack of evidence-based or widely accepted consensus on ...
Las Vegas, NV / Syndication Cloud / January 23, 2026 / ContrastConnect The American College of Radiology (ACR) and the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results